Ekso Bionics Holdings, Inc. (EKSO)
NASDAQ: EKSO · IEX Real-Time Price · USD
2.50
+0.62 (32.98%)
At close: Dec 29, 2023, 4:00 PM
2.55
+0.05 (2.00%)
After-hours: Dec 29, 2023, 7:58 PM EST
Ekso Bionics Holdings Revenue
Ekso Bionics Holdings had revenue of $16.98M in the twelve months ending September 30, 2023, with 26.39% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $4.61M with 38.39% year-over-year growth. In the year 2022, Ekso Bionics Holdings had annual revenue of $12.91M with 14.81% growth.
Revenue (ttm)
$16.98M
Revenue Growth
+26.39%
P/S Ratio
2.10
Revenue / Employee
$235,875
Employees
72
Market Cap
35.59M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 12.91M | 1.67M | 14.81% |
Dec 31, 2021 | 11.25M | 2.36M | 26.62% |
Dec 31, 2020 | 8.88M | -5.04M | -36.18% |
Dec 31, 2019 | 13.92M | 2.59M | 22.81% |
Dec 31, 2018 | 11.33M | 3.98M | 54.11% |
Dec 31, 2017 | 7.35M | -6.87M | -48.29% |
Dec 31, 2016 | 14.22M | 5.56M | 64.20% |
Dec 31, 2015 | 8.66M | 3.33M | 62.59% |
Dec 31, 2014 | 5.33M | 2.03M | 61.33% |
Dec 31, 2013 | 3.30M | 596.00K | 22.03% |
Dec 31, 2012 | 2.71M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NanoString Technologies | 162.47M |
Meihua International Medical Technologies Co. | 96.70M |
electroCore | 13.40M |
Homology Medicines | 1.96M |
Cyclo Therapeutics | 951.81K |
Synlogic | 708.00K |
Envoy Medical | 380.00K |
EKSO News
- 6 weeks ago - Ekso Bionics to Participate at Centers for Medicare & Medicaid Services (CMS) Second Biannual 2023 Healthcare Common Procedure Coding System (HCPCS) Public Meeting on Wednesday, November 29 - GlobeNewsWire
- 2 months ago - Centers for Medicare & Medicaid Services (CMS) Codifies Medicare Coverage for Ekso Indego Personal - GlobeNewsWire
- 2 months ago - Ekso Bionics Reports Third Quarter 2023 Revenue Growth of 38% - GlobeNewsWire
- 2 months ago - Ekso Bionics to Report Third Quarter 2023 Financial Results on October 26, 2023 - GlobeNewsWire
- 3 months ago - Ekso Bionics to Participate at the H.C. Wainwright 25th Annual Global Investment Conference - GlobeNewsWire
- 5 months ago - Ekso Bionics to Report Second Quarter 2023 Financial Results on July 27, 2023 - GlobeNewsWire
- 8 months ago - Ekso Bionics Announces 61% Increase in First Quarter 2023 Revenues - GlobeNewsWire
- 9 months ago - Ekso Bionics to Report First Quarter 2023 Financial Results on April 27, 2023 - GlobeNewsWire